Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

U.S. FDA approves Gilead's hepatitis C drug for expanded use

Friday, November 13, 2015

Drugmaker Gilead Sciences Inc said on Thursday the US Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug Harvoni The drug can now be used to treat patients with subtypes of chronic hepatitis C virus HCV an...

Germany, U.S. in hot pursuit of 'messenger' drug molecules

Friday, November 13, 2015

A molecule that carries the recipe for making drugs inside body cells is exciting scientists and investors alike attracting hundreds of millions of dollars in a scramble for the next promising area of biotechnology German and US firms are leading th...

Novartis, Roche find 'outcome-based' drug pricing an elusive dream

Friday, November 13, 2015

News that Novartiss heart drug Entresto cuts the risk of rehospitalization might have helped Chief Executive Joe Jimenez realize his ambition of getting insurers to pay more for treatments when they cut overall medical costs Instead Jimenez and Seve...

US court imposes temporary sales ban on Dr Reddy’s generic antacid

Thursday, November 12, 2015

A US court has temporarily stopped Dr Reddys Laboratories from selling a generic version of AstraZenecas antacid Nexium in that market over allegations of trademark infringement The order of the District Court in Delaware has come on a suit filed by...

BioDuro, LLC announces merger with Formex, LLC, and New Leadership

Thursday, November 12, 2015

BioDuro LLC a global CRO leader focused on preclinical chemistry biology and fully outsourced integrated drug development services for pharmaceutical partners announced the merger of its US operations with Formex LLC a leader in pharmaceutical API fo...

X-Rx announces Autotaxin Inhibitor collaboration with Gilead Sciences

Thursday, November 12, 2015

XRx Inc announced that it has entered into an exclusive agreement with Gilead Sciences Inc to develop XRxs proprietary small molecule autotaxin ATX inhibitors ATX plays a key role in maintaining tissue homeostasis and is upregulated in many diseases...

Alnylam, Medicines Co cholesterol drug effective for six months

Thursday, November 12, 2015

An experimental cholesterol fighter being developed by Alnylam Pharmaceuticals and The Medicines Co slashed levels of bad LDL cholesterol and remained effective for six months according to data from a small early stage study The drug called ALNPCSsc...

Sanofi delayed drug to avoid $708 million in payments, lawsuit claims

Tuesday, November 10, 2015

A new lawsuit accuses Sanofi SA of stalling development of its multiple sclerosis drug Lemtrada to avoid paying out at least million to rights holders under its agreement to acquire Genzyme Corp The lawsuit filed on Monday in Manhattan federal cou...

Lilly diabetes drug cuts heart failure death, hospitalization

Tuesday, November 10, 2015

Eli Lillys new diabetes drug Jardiance significantly cut the risk of heartrelated death and hospitalization for heart failure in patients with type diabetes who are at high risk for serious heart problems according to data from a large study present...

Nicox and Fera Pharmaceuticals sign exclusive license agreement for naproxcinod in the U.S.

Tuesday, November 10, 2015

Nicox SA the international ophthalmic company and Fera Pharmaceuticals a privatelyheld specialty pharmaceutical company announced today that they have entered into an exclusive license agreement for the development and commercialization of Nicoxs nap...